Related Experiment Videos
[Conn's syndrome and severe arrhythmias]
J Pella1, I Lazúrová, B Javorská
1III. interní klinika Fakultnej nemocnice L. Pasteura, Kosice.
Vnitrni Lekarstvi
|October 25, 2000
Summary
Conn's syndrome, caused by a solitary adrenal adenoma, can manifest as atrial fibrillation. Fluctuating potassium levels and anti-arrhythmic drugs may trigger life-threatening ventricular tachycardia in these patients.
Area of Science:
- Endocrinology
- Cardiology
- Internal Medicine
Background:
- Conn's syndrome, or primary hyperaldosteronism, is characterized by excessive aldosterone secretion from the adrenal glands.
- It is often caused by an adrenal adenoma or bilateral adrenal hyperplasia.
- Commonly presents with hypertension and hypokalemia, but cardiac arrhythmias can be initial or presenting symptoms.
Observation:
- The case involves a patient presenting with "lone" atrial fibrillation, initially without identifiable organic cardiac causes.
- The underlying pathology was found to be a solitary cortical adenoma of the adrenal gland (Conn's syndrome).
- Variable serum potassium levels and anti-arrhythmic drug treatment for atrial fibrillation were noted.
Findings:
- A solitary adrenal adenoma (Conn's syndrome) was the cause of the patient's atrial fibrillation.
- Fluctuations in serum potassium levels acted as a trigger for ventricular tachycardia.
- Treatment for atrial fibrillation with anti-arrhythmic medications contributed to the life-threatening cardiac event.
Implications:
- This case highlights the importance of considering endocrine disorders like Conn's syndrome in patients with unexplained arrhythmias.
- It underscores the critical role of electrolyte balance, particularly potassium, in managing cardiac rhythm disturbances.
- Early diagnosis and management of adrenal adenomas are crucial to prevent severe cardiac complications.